Yazan F. Madanat

Statistics

Publications

Citations

1.2K

H-Index

Active since

2016

Affiliations

The University of Texas Southwestern Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Cleveland Clinic

Massachusetts General Hospital

Yazan F. Madanat is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2016–2025

Publications

<i>TP53</i> mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Olga K. Weinberg, Alexa J. Siddon, Yazan F. Madanat et al. · Blood Advances · 2022 · 194 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Aaron T. Gerds, Jason Gotlib, Haris Ali et al. · Journal of the National Comprehensive Cancer Network · 2022 · 133 citations · Full text

Medicine, Hematology, Oncology +17

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial

Uwe Platzbecker, Valeria Santini, Pierre Fenaux et al. · The Lancet · 2023 · 132 citations

Medicine, Hematology, Pharmacology +8

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022

Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali et al. · Journal of the National Comprehensive Cancer Network · 2022 · 125 citations · Full text

Medicine, Hematology, Oncology +17

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet et al. · Blood · 2022 · 56 citations · Full text

Medicine, Hematology, Oncology +9

1–5 of 30